| 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 国际贸易(元) | 2,829,697,588.83 | 8,434,398,596.48 | 6,836,368,835.08 |
| 内部抵销(元) | -151,417,642.59 | -2,233,018,937.03 | -3,913,762,689.22 |
| 医药工业(元) | 1,590,757,357.04 | 3,335,489,330.13 | 1,721,315,792.83 |
| 医药商业(元) | 13,528,284,925.45 | 29,287,561,515.27 | 16,981,049,287.85 |
| 营业成本(元) | |||
| 国际贸易(元) | 3,650,356,275.86 | 7,684,357,551.75 | 6,398,005,311.77 |
| 内部抵销(元) | -5,562,117,209.67 | -2,225,424,872.76 | -3,935,111,548.67 |
| 医药工业(元) | 1,661,458,143.21 | 2,045,767,341.51 | 1,005,348,977.89 |
| 医药商业(元) | 16,106,336,056.13 | 26,936,113,663.54 | 15,752,876,080.92 |
| 毛利(元) | |||
| 国际贸易(元) | -820,658,687.03 | 750,041,044.73 | 438,363,523.31 |
| 内部抵销(元) | 5,410,699,567.08 | -7,594,064.27 | 21,348,859.45 |
| 医药工业(元) | -70,700,786.17 | 1,289,721,988.62 | 715,966,814.94 |
| 医药商业(元) | -2,578,051,130.68 | 2,351,447,851.73 | 1,228,173,206.93 |
| 毛利率(%) | |||
| 国际贸易(%) | -29.00 | 8.89 | 6.41 |
| 内部抵销(%) | -3,573.36 | 0.34 | -0.55 |
| 医药工业(%) | -4.44 | 38.67 | 41.59 |
| 医药商业(%) | -19.06 | 8.03 | 7.23 |
| 收入构成(%) | |||
| 国际贸易(%) | 15.90 | 21.72 | 31.61 |
| 内部抵销(%) | -0.85 | -5.75 | -18.10 |
| 医药工业(%) | 8.94 | 8.59 | 7.96 |
| 医药商业(%) | 76.01 | 75.44 | 78.53 |
| 毛利构成(%) | |||
| 国际贸易(%) | -42.27 | 17.11 | 18.24 |
| 内部抵销(%) | 278.72 | -0.17 | 0.89 |
| 医药工业(%) | -3.64 | 29.42 | 29.78 |
| 医药商业(%) | -132.80 | 53.64 | 51.09 |